AI Article Synopsis

Article Abstract

Objective: Parkinson's disease (PD) is a neurodegenerative disorder (ND) due to progressive loss of dopaminergic neurons in the basal ganglia. The correct differential diagnosis of this disease with parkinsonian syndromes (PS) or with essential tremor (ET) is a diagnostic dilemma, considering that only PD is responsive to treatment with levodopa. Traditional imaging fails to diagnose PD because morphological alterations in the brain are usually detectable only at advanced stages. Single photon emission tomography (SPET) with cocaine analogues has recently been used in the early detection of PD. The fluoro-18-deoxyphenyl-alanine ((18)F-DOPA) is a positron emission tomography (PET) tracer with selective in vivo affinity to the basal ganglia, due to the specific metabolism of substantia nigra. We assessed the effective use of (18)F-DOPA PET in brain imaging in order to describe the function of presynaptic disorders of PD, PS, ET and other movement disorders compared to SPET imaging and also discussed novel radiopharmaceuticals. The role of magnetic resonance imaging (MRI) was also discussed.

Conclusion: (18)F-DOPA PET imaging is still the best diagnostic tool for the diagnosis of PD and other movement disorders. Fluorine-18-FDG PET can play a role in the differential diagnosis between PD and other PS. The hybrid (18)F-DOPA PET/MRI seems to be able to play an important additional role in early diagnosis of the above syndromes.

Download full-text PDF

Source
http://dx.doi.org/10.1967/s002449910335DOI Listing

Publication Analysis

Top Keywords

18f-dopa pet
12
movement disorders
12
brain imaging
8
basal ganglia
8
differential diagnosis
8
emission tomography
8
imaging
6
18f-dopa
5
pet
5
current status
4

Similar Publications

Pheochromocytomas and paragangliomas (PPGLs) are rare neuroendocrine tumors derived from chromaffin cells, with 80-85% originating in the adrenal medulla and 15-20% from extra-adrenal chromaffin tissues (paragangliomas). Approximately 30-40% of PPGLs have a hereditary component, making them one of the most genetically predisposed tumor types. Recent advances in genetic research have classified PPGLs into three molecular clusters: pseudohypoxia-related, kinase-signaling, and -signaling pathway variants.

View Article and Find Full Text PDF

Purpose: To investigate the influence of germline succinate dehydrogenase (SDHx) pathogenic variants on 6-[F]-fluoro-3,4-dihydroxyphenylalanine (F-DOPA) Positron Emission Tomography (PET) radiomic signature of head and neck paragangliomas (HNPGLs).

Methods: Forty-seven patients (20 SDH pathogenic variants carriers) harboring 55 HNPGLs were retrospectively included. HNPGLs were delineated using Nestle adaptive threshold.

View Article and Find Full Text PDF

Objectives: Congenital syphilis can cause severe morbidities such as hydrops fetalis, preterm birth, low birth weight, hepatosplenomegaly, pneumonia, hypoglycemia, etc., and mortality. Despite hypoglycemia being reported in congenital syphilis and hyperinsulinism, only one case was described.

View Article and Find Full Text PDF

[Not Available].

Bull Cancer

October 2024

Service de médecine nucléaire et UCP thyroïde, Centre François-Badesse, 3, avenue du Général-Harris, 14000 Caen, France.

Article Synopsis
  • Nuclear medicine continues to play a vital role in treating thyroid cancers, specifically through the use of iodine-131 (RAI) for differentiated thyroid cancer (DTC) and post-therapeutic scintigraphy to assess treatment response.
  • For challenging cases where RAI isn't effective, FDG PET imaging aids in diagnosis and prognosis, particularly for less than 5% of those with refractory disease and for aggressive anaplastic thyroid cancer.
  • Emerging theranostic strategies are being developed using various radiopharmaceuticals and imaging methods like 18F-DOPA, PSMA, and FAP, highlighting a shift from traditional treatments towards more personalized approaches in managing thyroid cancer.
View Article and Find Full Text PDF

[18F]DOPA PET for lesion definition and contouring using different thresholds in patients with gliomas.

Q J Nucl Med Mol Imaging

September 2024

Nuclear Medicine Unit, Department of Medical Sciences, AOU Città della Salute e della Scienza, Turin, Italy -

Article Synopsis
  • The study examines the effectiveness of ESTRO-EANO guidelines for RT-planning in glioblastomas using [F]DOPA-PET, comparing their target definition thresholds (1.6-1.8) with traditional biological-tumor-volume (BTV) thresholds derived from the striatum. !* -
  • An analysis of 50 glioma patients found that the striatum SUVmax threshold often resulted in smaller and less accurate tumor volumes, with significant discrepancies noted in many cases. !* -
  • The research concludes that the ESTRO-EANO thresholds for defining tumor volume are compatible with [F]DOPA-PET scans, while using the striatal SUV
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!